Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Systematic Mapping Study
100%
Lung Cancer Survival
100%
Overview of Systematic Reviews
100%
Review of Systematic Reviews
100%
Prognostic Factors
100%
Modifiable Factors
50%
Overview of Reviews
33%
Mapping Review
25%
Wales
25%
Lung Cancer
25%
Welsh
25%
Large Volume
16%
Clinical Characteristics
16%
Novel Biomarkers
16%
Predictive Factors
16%
Tumor Characteristics
16%
Metabolic Activity
16%
Patient Characteristics
16%
Meta-analysis
16%
Prognostic Model
8%
Cardiothoracic Surgeon
8%
Cancer Site
8%
Survival Rate
8%
Multiple Cancers
8%
Non-small Cell Lung Cancer (NSCLC)
8%
Normal BMI
8%
Prognostic Research
8%
Biological Factors
8%
Tumor Metabolism
8%
Short Intervals
8%
Biological Variables
8%
Non-smokers
8%
Last Five Years
8%
Quit Smoking
8%
Survivin
8%
Five-factor
8%
Clinical Practice
8%
ERCC1
8%
Postoperative Mortality
8%
Healthcare Professionals
8%
Tumor
8%
Improved Survival
8%
Cancer Outcomes
8%
Medical Insurance
8%
Differential Treatment
8%
MicroRNA-155 (miR-155)
8%
Procedural Volume
8%
Emergency Admissions
8%
Multivariate Model
8%
New Biomarkers
8%
Multivariate Modeling
8%
Cancer Lung
8%
Waiting Time Paradox
8%
Lung Resection
8%
Cancer Types
8%
Multidisciplinary Team
8%
Treatment Quality
8%
Poor Prognosis
8%
Statistical Significance
8%
Provider Factors
8%
Performance Status
8%
C-X-C Chemokine Receptor Type 4 (CXCR4)
8%
Thoracic Surgeons
8%
Cancer Causes
8%
Epidermal Growth Factor Receptor
8%
Poor Outcome
8%
Cancer Research
8%
Good Quality
8%
Improved Outcomes
8%
Multivariate Analysis
8%
Overexpression
8%
Overall Survival
8%
K-ras
8%
Nodal Status
8%
Presentation Mode
8%
Health Systems
8%
Future Health
8%
General Surgeon
8%
Kirsten Rat Sarcoma Viral Oncogene Homolog
8%
Growing Tumor
8%
MicroRNA-21 (miR-21)
8%
Early Tumor
8%
Lung Squamous Cell Carcinoma
8%
Most Common Form
8%
Epithelial Cadherin
8%
General Well-being
8%
Lung Adenocarcinoma
8%
C-reactive Protein
8%
Treatment Response
8%
Evidence-based
8%
Metastatic Tumor
8%
Pragmatic Approach
8%
Quality of Life
8%
Narrative Synthesis
8%
Treatment Plan
8%
Prognostic Factor Research
8%
Weight Loss
8%
Patient Care
8%
Cancer Mortality
8%
Activities of Daily Living
8%
Early Cancer
8%
Timeliness of Care
8%
Lung
8%
System Factors
8%
Positron Emission Tomography-computed Tomography (PET-CT)
8%
Initial Mapping
8%
Histology
8%
Health Outcomes
8%
Systematic Meta-analysis
8%
Medicine and Dentistry
Lung Cancer Survival
100%
Systematic Review
100%
Prognostic Factor
100%
Malignant Neoplasm
58%
Neoplasm
33%
Biological Marker
25%
Lung Cancer
25%
Patient Characteristics
16%
Cancer Staging
16%
Meta-Analysis
16%
Surgeon
16%
Predictive Factor
16%
Protein P53
8%
Cadherin
8%
Epidermal Growth Factor Receptor
8%
Base Excision Repair
8%
Gamma Chemokine
8%
Squamous Cell Lung Carcinoma
8%
Virus Oncogene
8%
Overall Survival
8%
Cancer Mortality
8%
Quality of Life
8%
Chemokine Receptor
8%
Surgical Mortality
8%
Survivin
8%
Patient Care
8%
C Reactive Protein
8%
microRNA 155
8%
Treatment Response
8%
Health Outcomes
8%
Positron Emission Tomography-Computed Tomography
8%
microRNA 21
8%
Pneumonectomy
8%
Disease
8%
Metastatic Carcinoma
8%
Body Mass Index
8%
Computer Assisted Tomography
8%
Connective Tissue Cancer
8%
Cardiothoracics
8%
Multivariate Analysis
8%
Biological Factor
8%
Non Small Cell Lung Cancer
8%
Lung Adenocarcinoma
8%
Small Cell Lung Cancer
8%
Smoking
8%
Cancer Localization
8%
Clinician
8%
Proteus Syndrome
8%
Survival Rate
8%
Lung
8%
Guanine Nucleotide Binding Protein
8%
Cancer Research
8%
Nursing and Health Professions
Lung Cancer
100%
Cancer Survival
100%
Systematic Review
100%
Malignant Neoplasm
63%
Neoplasm
27%
Biological Marker
27%
Thoracic Surgeon
18%
Cancer Staging
18%
Meta Analysis
18%
Surgeon
9%
Surgical Mortality
9%
Lung Resection
9%
Cadherin
9%
Biological Factor
9%
Disease
9%
Multiple Cancer
9%
Computer Assisted Tomography
9%
Patient Care
9%
Squamous Cell Lung Carcinoma
9%
C Reactive Protein
9%
microRNA 21
9%
Small Cell Lung Cancer
9%
Cancer Research
9%
Non Small Cell Lung Cancer
9%
microRNA 155
9%
Positron Emission Tomography-Computed Tomography
9%
Health Outcomes
9%
Cancer Mortality
9%
Survivin
9%
Health Care Personnel
9%
Clinical Practice
9%
Epidermal Growth Factor Receptor
9%
Multivariate Analysis
9%
Gross Tumor Volume
9%
Survival Rate
9%
Protein P53
9%
Guanine Nucleotide Binding Protein
9%
Connective Tissue Cancer
9%
Metastasis
9%
Healthcare System
9%
Quality of Life
9%
Chemokine Receptor
9%
Independent Practice Association
9%
Gamma Chemokine
9%
Treatment Response
9%
Lung Adenocarcinoma
9%
Overall Survival
9%
Cancer Localization
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Cancer Survival
100%
Malignant Neoplasm
58%
Neoplasm
33%
Biological Marker
25%
Cancer Staging
16%
Multiple Cancer
8%
C Reactive Protein
8%
Disease
8%
Overall Survival
8%
Biological Factor
8%
Lung Adenocarcinoma
8%
Cadherin
8%
Small Cell Lung Cancer
8%
Non Small Cell Lung Cancer
8%
Connective Tissue Cancer
8%
microRNA 21
8%
Squamous Cell Lung Carcinoma
8%
Surgical Mortality
8%
Survival Rate
8%
Metastasis
8%
Protein P53
8%
Epidermal Growth Factor Receptor
8%
Gamma Chemokine
8%
Chemokine Receptor
8%
Cancer Mortality
8%
Guanine Nucleotide Binding Protein
8%
microRNA 155
8%
Survivin
8%